Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Tumor Embolization Devices Market From 2025 To 2029?

In recent times, we’ve seen significant growth in the tumor embolization devices market. It’s projected to expand from $1493.6 billion in 2024 to a staggering $1600.57 billion in 2025, representing a compound annual growth rate (CAGR) of 7.2%. Factors such as minimally invasive procedures, technological progress, cancer prevalence, and an aging population are the driving forces behind the growth experienced in the historical period.

What Is the Projected Market Size of the Tumor Embolization Devices Market?

The market for tumor embolization devices is predicted to witness robust expansion in the forthcoming years. It is projected to reach a value of $2286.1 billion by 2029, increasing at a compound annual growth rate (CAGR) of 9.3%. This uptrend during the estimated period can be credited to factors such as personalized healthcare, hybrid therapies, image-led embolization, telemedicine, and distant consultations. Key developments anticipated during this period encompass breakthroughs in embolic agents, transarterial chemoembolization (tace), embolization for effective palliative care, and image-directed operations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

Who are the Major Competitors in the Tumor Embolization Devices Market Outlook?

Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

What Is Fueling Growth in the Tumor Embolization Devices Market?

The global increase in cancer cases is expected to spur the expansion of the tumor embolization devices market in the projected timeline. To illustrate, Macmillan Cancer Support, a leading healthcare charity organization in the UK, predicted in October 2022 that by 2025, 3.5 million people would have cancer, 4 million by 2030, and by 2040, the number is projected to reach 5.3 million. As a result, the escalating rate of cancer globally will likely heighten the demand for the tumor embolization market in the coming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp

Which Tumor Embolization Devices Market Segments Are Growing the Fastest?

The tumor embolization devices market covered in this report is segmented –

1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents

2) By Application: Cancer Tumors, Noncancerous Tumors

3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Subsegments:

1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres

2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol – PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)

Which Industry Trends Are Shaping the Future of the Tumor Embolization Devices Market?

Leading firms in the tumor embolization devices market are introducing innovations such as angiography systems to improve the precision and efficacy of treatments targeting tumors. Angiography systems are advanced imaging devices that provide a visualization of blood vessels and measure blood flow within the body. For example, Siemens Healthineers, a healthcare company based in Germany, unveiled the Artis Icono Ceiling in June 2022. This is an angiography system attached to the ceiling setup, developed specifically to enhance accuracy in tumor embolization and other similar procedures. The Artis Icono Ceiling has the feature of fast 3D data acquisition, able to take images at the patient’s head in a mere 2.5 seconds, and from the sides in 4 seconds. This lessens motion distortions and lowers the dependence on contrast media. The design of the Artis Icono Ceiling offers adaptability, making it usable across different disciplines, such as interventional radiology and cardiology.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Which Countries Are Leading the Tumor Embolization Devices Market?

North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352

This Report Delivers Insight On:

1. How big is the tumor embolization devices market, and how is it changing globally?

2. Who are the major companies in the tumor embolization devices market, and how are they performing?

3. What are the key opportunities and risks in the tumor embolization devices market right now?

4. Which products or customer segments are growing the most in the tumor embolization devices market?

5. What factors are helping or slowing down the growth of the tumor embolization devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model